| 1 |
35062972 | Bacteria-engineered porous sponge for hemostasis and vascularization. | 2022 Jan 21 |
2 |
| 2 |
34019306 | Treatment with hypoxia-mimetics protects cultured rat Schwann cells against oxidative stress-induced cell death. | 2021 Sep |
4 |
| 3 |
34763682 | Experimental study of the effects of hypoxia simulator on osteointegration of titanium prosthesis in osteoporotic rats. | 2021 Nov 11 |
2 |
| 4 |
34916700 | [Early constant observation of the effect of deferoxamine mesylate on improvement of vascularized bone regeneration in SD rat skull critical size defect model]. | 2021 Dec 18 |
6 |
| 5 |
31630885 | HIF-1α and VEGF Are Involved in Deferoxamine-Ameliorated Traumatic Brain Injury. | 2020 Feb |
5 |
| 6 |
32140105 | Deferoxamine Treatment Combined With Sevoflurane Postconditioning Attenuates Myocardial Ischemia-Reperfusion Injury by Restoring HIF-1/BNIP3-Mediated Mitochondrial Autophagy in GK Rats. | 2020 |
1 |
| 7 |
32383023 | Deferoxamine Ameliorates Compressed Spinal Cord Injury by Promoting Neovascularization in Rats. | 2020 Sep |
2 |
| 8 |
33029500 | Combined Pharmacotherapy with Alendronate and Desferoxamine Regulate the Bone Resorption and Bone Regeneration for Preventing Glucocorticoids-Induced Osteonecrosis of the Femoral Head. | 2020 |
1 |
| 9 |
31228457 | Lecithin-based deferoxamine nanoparticles accelerated cutaneous wound healing in diabetic rats. | 2019 Sep 5 |
1 |
| 10 |
29341316 | Deferoxamine promotes mesenchymal stem cell homing in noise-induced injured cochlea through PI3K/AKT pathway. | 2018 Apr |
1 |
| 11 |
26101070 | Deferoxamine modulates cytokines and growth factors to accelerate cutaneous wound healing in diabetic rats. | 2015 Oct 5 |
1 |
| 12 |
26332145 | Deferoxamine preconditioning to restore impaired HIF-1α-mediated angiogenic mechanisms in adipose-derived stem cells from STZ-induced type 1 diabetic rats. | 2015 Oct |
1 |
| 13 |
26339170 | Deferoxamine Improves Alveolar and Pulmonary Vascular Development by Upregulating Hypoxia-inducible Factor-1α in a Rat Model of Bronchopulmonary Dysplasia. | 2015 Sep |
5 |
| 14 |
24375098 | Hypoxia selectively disrupts brain microvascular endothelial tight junction complexes through a hypoxia-inducible factor-1 (HIF-1) dependent mechanism. | 2014 Aug |
1 |
| 15 |
25075254 | Desferrioxamine regulates HIF-1 alpha expression in neonatal rat brain after hypoxia-ischemia. | 2014 |
6 |
| 16 |
25152469 | Beneficial effects of deferoxamine against astrocyte death induced by modified oxygen glucose deprivation. | 2014 Oct 2 |
1 |
| 17 |
23536977 | Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin-diabetic rats. | 2013 Jul |
6 |
| 18 |
23726275 | Deferoxamine enhances neovascularization and accelerates wound healing in diabetic rats via the accumulation of hypoxia-inducible factor-1α. | 2013 Jul |
4 |
| 19 |
21302291 | Hypoxia-inducible factor 1 mediates increased expression of NADPH oxidase-2 in response to intermittent hypoxia. | 2011 Nov |
1 |
| 20 |
17139180 | Hypoxia represses the differentiation of Rcho-1 rat trophoblast giant cells. | 2007 |
1 |
| 21 |
17637177 | Dihydroartemisinin exerts cytotoxic effects and inhibits hypoxia inducible factor-1alpha activation in C6 glioma cells. | 2007 Jun |
1 |
| 22 |
16623832 | Delayed administration of deferoxamine reduces brain damage and promotes functional recovery after transient focal cerebral ischemia in the rat. | 2006 Apr |
1 |
| 23 |
16023639 | Hypoxia-inducible factor 1alpha and erythropoietin upregulation with deferoxamine salvage after neonatal stroke. | 2005 Oct |
2 |
| 24 |
16046841 | Hypoxia preconditioning in the brain. | 2005 Mar-Aug |
1 |